Biotechnology
Compare Stocks
2 / 10Stock Comparison
NTRB vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
NTRB vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market Cap | $46M | $1.61B |
| Revenue (TTM) | $2M | $4.18B |
| Net Income (TTM) | $-8M | $-1.82B |
| Gross Margin | 24.9% | 34.2% |
| Operating Margin | -408.4% | -4.1% |
| Forward P/E | — | 5.6x |
| Total Debt | $210K | $3.97B |
| Cash & Equiv. | $5M | $532M |
NTRB vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Nutriband Inc. (NTRB) | 100 | 70.6 | -29.4% |
| Perrigo Company plc (PRGO) | 100 | 26.0 | -74.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NTRB vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NTRB is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -4.8%, EPS growth -160.6%, 3Y rev CAGR -0.7%
- -34.0% 10Y total return vs PRGO's -77.7%
- Lower volatility, beta 1.20, Low D/E 3.1%, current ratio 6.36x
PRGO carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- Beta 1.18, yield 9.8%, current ratio 2.76x
- -2.8% revenue growth vs NTRB's -4.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.8% revenue growth vs NTRB's -4.8% | |
| Quality / Margins | -43.5% margin vs NTRB's -404.1% | |
| Stability / Safety | Beta 1.18 vs NTRB's 1.20 | |
| Dividends | 9.8% yield; 10-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -34.4% vs PRGO's -51.2% | |
| Efficiency (ROA) | -19.8% ROA vs NTRB's -101.9%, ROIC 3.7% vs -270.2% |
NTRB vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NTRB vs PRGO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PRGO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 2051.6x NTRB's $2M. Profitability is closely matched — net margins range from -43.5% (PRGO) to -4.0% (NTRB). On growth, PRGO holds the edge at -7.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2M | $4.2B |
| EBITDAEarnings before interest/tax | -$8M | $58M |
| Net IncomeAfter-tax profit | -$8M | -$1.8B |
| Free Cash FlowCash after capex | -$5M | $108M |
| Gross MarginGross profit ÷ Revenue | +24.9% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -4.1% | -4.1% |
| Net MarginNet income ÷ Revenue | -4.0% | -43.5% |
| FCF MarginFCF ÷ Revenue | -2.5% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -37.6% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +84.4% | -56.4% |
Valuation Metrics
PRGO leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $46M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $42M | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | -1.47x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.42x |
| Price / SalesMarket cap ÷ Revenue | 22.66x | 0.38x |
| Price / BookPrice ÷ Book value/share | 6.61x | 0.55x |
| Price / FCFMarket cap ÷ FCF | — | 11.12x |
Profitability & Efficiency
PRGO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
PRGO delivers a -50.7% return on equity — every $100 of shareholder capital generates $-51 in annual profit, vs $-118 for NTRB. NTRB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), PRGO scores 4/9 vs NTRB's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -118.3% | -50.7% |
| ROA (TTM)Return on assets | -101.9% | -19.8% |
| ROICReturn on invested capital | -2.7% | +3.7% |
| ROCEReturn on capital employed | -125.5% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.03x | 1.35x |
| Net DebtTotal debt minus cash | -$4M | $3.4B |
| Cash & Equiv.Liquid assets | $5M | $532M |
| Total DebtShort + long-term debt | $209,629 | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -369.11x | -7.20x |
Total Returns (Dividends Reinvested)
NTRB leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTRB five years ago would be worth $6,603 today (with dividends reinvested), compared to $3,986 for PRGO. Over the past 12 months, NTRB leads with a -34.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors NTRB at 3.5% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.4% | -13.5% |
| 1-Year ReturnPast 12 months | -34.4% | -51.2% |
| 3-Year ReturnCumulative with dividends | +10.8% | -58.1% |
| 5-Year ReturnCumulative with dividends | -34.0% | -60.1% |
| 10-Year ReturnCumulative with dividends | -34.0% | -77.7% |
| CAGR (3Y)Annualised 3-year return | +3.5% | -25.2% |
Risk & Volatility
PRGO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PRGO is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than NTRB's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRGO currently trades 41.2% from its 52-week high vs NTRB's 32.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.20x | 1.18x |
| 52-Week HighHighest price in past year | $11.68 | $28.44 |
| 52-Week LowLowest price in past year | $3.42 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +32.4% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 50.8 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 11K | 3.4M |
Analyst Outlook
PRGO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $20.00 |
| # AnalystsCovering analysts | — | 36 |
| Dividend YieldAnnual dividend ÷ price | — | +9.8% |
| Dividend StreakConsecutive years of raises | 1 | 10 |
| Dividend / ShareAnnual DPS | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
PRGO leads in 5 of 6 categories (Income & Cash Flow, Valuation Metrics). NTRB leads in 1 (Total Returns).
NTRB vs PRGO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NTRB or PRGO a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -4. 8% for Nutriband Inc. (NTRB). Analysts rate Perrigo Company plc (PRGO) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NTRB or PRGO?
Over the past 5 years, Nutriband Inc.
(NTRB) delivered a total return of -34. 0%, compared to -60. 1% for Perrigo Company plc (PRGO). Over 10 years, the gap is even starker: NTRB returned -34. 0% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NTRB or PRGO?
By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.
18β versus Nutriband Inc. 's 1. 20β — meaning NTRB is approximately 2% more volatile than PRGO relative to the S&P 500. On balance sheet safety, Nutriband Inc. (NTRB) carries a lower debt/equity ratio of 3% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
04Which is growing faster — NTRB or PRGO?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -4. 8% for Nutriband Inc. (NTRB). On earnings-per-share growth, the picture is similar: Nutriband Inc. grew EPS -160. 6% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, NTRB leads at -0. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NTRB or PRGO?
Perrigo Company plc (PRGO) is the more profitable company, earning -33.
5% net margin versus -404. 1% for Nutriband Inc. — meaning it keeps -33. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -408. 4% for NTRB. At the gross margin level — before operating expenses — PRGO leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NTRB or PRGO?
In this comparison, PRGO (9.
8% yield) pays a dividend. NTRB does not pay a meaningful dividend and should not be held primarily for income.
07Is NTRB or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, NTRB: -34. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NTRB and PRGO?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NTRB is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while NTRB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.